Kluszczynska K, Czyz M: Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. (2023) Int J Mol Sci. 24(2):965. https://pubmed.ncbi.nlm.nih.gov/36674479/
Bojarska J, Breza M, Remko M, Czyz M, Gajos-Michniewicz A, Zimecki M, Kaczmarek K, Madura ID, Wojciechowski JM, Wolf WM: Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond. (2022) Int J Mol Sci. 23(13):7173. https://pubmed.ncbi.nlm.nih.gov/35806175/
Pastwa E, Somiari SB, Czyz M, Somiari RI: Proteomics in human cancer research. (2007) Proteomics Clinical Application 1: 4-17 (Zakład Genetyki Molekularnej UM w Łodzi)
KONFERENCJE od roku 2007
Hartman ML, Gajos-Michniewicz A, Talaj J.A., Mielczarek-Lewandowska A, Czyz M Encorafenib alters melanoma cell proximity to the apoptotic threshold – implications for complementary therapeutic strategy using selective BH3 mimetics. XXIV Gliwice Scientific Meetings, Gliwice, Poland, 20-21 November 2020
Czyz M, Osrodek M, Gajos-Michniewicz A, Sztiller-Sikorska M Oxygen concentration contributes to phenotypic heterogeneity of melanoma during adaptive response to targeted therapeutics. Nature Conference on Cellular Metabolism; Xiamen, China, 8-11 April 2019
Osrodek M, Hartman ML, Czyz M Response of melanoma cells to vemurafenib and trametinib at the level of metabolic phenotype. Nature Conference on Cellular Metabolism; Xiamen, China, 8-11 April 2019
Rogut ME, Hartman ML, Mielczarek-Lewandowska A, Sztiller-Sikorska M, Gajos-Michniewicz A, Czyz M The effect of 17-aminogeldanamycin on NF-κB activity in patient-derived melanoma cell lines. 11th International Conference of Contemporary Oncology, Poznań, Poland 13-15 March 2019
Mielczarek-Lewandowska A, Hartman ML, Sztiller-Sikorska M, Osrodek M, Gajos-Michniewicz A, Czyz M 17-aminogeldanamycin inhibits cytoprotective UPR pathways and cooperates with inhibitors of the MAPK signaling cascade in apoptosis induction. Melanoma: from biology to target; Houston, USA 15-18 January 2019
Rogut M, Zietara M, Hartman ML, Czyz M, Wilczynski J, Szubert M Is it possible to diagnose endometriosis at the level of endometrium? Gynecological Endocrinology: The 18th World Congress; Florence, Italy, 7-10 March 2018 Czyż M (Speaker) Feverfew and parthenolide – phytochemical, pharmacological and clinical evidence. A Scientific Workshop; Vienna, Austria, 16 November 2017
Hartman ML, Sztiller-Sikorska M, Ośrodek M, Zaleśna I, Mielczarek A, Czyż M V600EBRAF melanoma cell response to vemurafenib and trametinib is not affected by exogenous growth factors bFGF, EGF and HGF in vitro. 9th World Congress of Melanoma; Brisbane, Australia; 18-21 October 2017
Ośrodek M, Hartman ML, Różański M, Sztiller-Sikorska M, Niewinna K, Czyż M Composition or lack of exogenous growth factors do not influence viability and phenotype of drug- naïve V600EBRAF melanoma cells but it might be crucial for drug-resistant cells. 9th World Congress of Melanoma; Brisbane, Australia; 18-21 October 2017
Hartman M, Gajos-Michniewicz A, Talar B, Czyż M MCL-1 protects patient-derived melanoma cells from death during rapid changes in microenvironment. EACR Conference Series: A Matter of Life or Death; Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment 2016; Amsterdam, Netherlands; 28-30 January 2016
Zaleśna I, Różański M, Sztiller-Sikorska M, Hartman M, Czyż M: Melanoma cell plasticity in response to diverse growth factors. EMBL Symposium: Tumor Microenvironment and Signalling 2016; Heidelberg, Germany; 03-06 April 2016
Ośrodek M, Hartman M, Różański M, Zaleśna I, Talar B, Niewinna K, Sztiller-Sikorska M, Nowicki J, Nejc D, Czyż M: Response of patient-derived melanoma cells to different growth factors. 2nd EACR Conference: Goodbye Flat Biology; Models, Mechanisms and Microenvironment 2016; Berlin, Germany; 02-05 October 2016
Hartman ML, Stiller-Sikorska M, Mielczarek A, Talar B, Nejc D, Czyż M: Natural compound parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-Mhigh melanoma cell populations. XXth Gliwice Scientific Meetings 2016; Gliwice, Poland; 18-19 November 2016
Talar B, Gajos-Michniewicz A, Czyż M: Modulation of canonical WNT pathway In patent-derived melanoma cell lines by natura compounds. Conference for Young Scientists 2015; Kijów, Ukraina; 21-25 September 2015
Gajos-Michniewicz A, Talar B, Hartman ML, Czyż M: Microenvironment-driven alterations of invasive potential of patent-derived melanoma cells. Conference for Young Scientists 2015; Kijów, Ukraina; 21-25 September 2015
Hartman ML, Sztiller-Sikorska M, Talar B, Gajos-Michniewicz A, Czyż M: Immediate and long-term molecular response of melanoma cells to changes in microenvironment. XVIIIth Gliwice Scientific Meetings 2014; Gliwice, 21-22 November 2014
Czyż M, Majchrzak K, Koprowska K, Hartman M, Sztiller-Sikorska M: Short- and long-term effects of natural compounds on melanoma cells derived from surgical specimens. Cell Death Signaling In Cancer and the Immune System; Guaruja, Sao Paulo, Brazil; 28 October – 2 November 2014
Hartman M, Talar B, Gajos-Michniewicz A, Czyż M: Diverse pro-survival responses of heterogeneous melanoma cell lines to changes in microenvironment. Cell Death Signaling In Cancer and the Immune System; Guaruja, Sao Paulo, Brazil; 28 October – 2 November 2014
Toma M, Gajos-Michniewicz A, Majchrzak K, Wieteska Ł, Szemraj J, Czyż M, Skorski T, Śliwiński T: Personalized synthetic lethality induced by targeting RAD52 and PARP1 in melanomas. The Ninth International Conference of Anticancer Research; Sithonia, Greece; 6-10 October 2014
Woźniak M, Gajos-Michniewicz A, Sztiller-Sikorska M, Pęczek Ł, Duechler M, Czyż M: MiRNAs from exosomes released by melanoma cells grown in 3-dimensional manner. Tissue Models and Drug Screening Conference; Berlin; 6-7 May 2014
Sztiller-Sikorska M, Majchrzak K, Hartman M, Czyż M: Short- and long-term effects of natural compounds on melanoma cells grown in anchorage-independent manner. Tissue Models and Drug Screening Conference; Berlin; 6-7 May 2014
Czyż M (Invited Speaker): Heterogeneity of melanospheres: therapeutic implications. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
Hartman MŁ, Sztiller-Sikorska M, Talar B, Chouaib S, Czyż M: Transcriptome profiles of melanospheres and monolayers derived from nodular melanoma specimens. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
Talar B, Sztiller-Sikorska M, Gajos-Michniewicz A, Koprowska K, Czyż M: Phenotypic heterogeneity and plasticity of cells in melanospheres derived from nodular melanoma specimens. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
Woźniak M, Sztiller-Sikorska M, Czyż M: Differential expression of microRNA in diverse phenotypes of melanoma cells. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
Czyż M, Hartman M, Talar B, Gajos-Michniewicz A, Zaleśna I, Sztiller-Sikorska M, Zaeem N, Salem C: Melanoma morphologic, molecular and functional diversity in vitro. Nature – CNIO Cancer Symposium on Frontiers in Tumour Heterogeneity and Plasticity; Madrid, Spain; 27-30 October 2013
Czyż M (Invited Expert): Heterogeneity and plasticity of melanospheres: implications for development of therapeutic strategies. European Cooperation in Science and Technology, COST Action CM1106 2nd Working Group Meeting. Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells; Warsaw, 19-20 September 2013
Pastuszko A, Kupcewicz B, Czyż M, Małecka M, Budzisz E: Cytotoxic activity of novel half-sandwich organoruthenium(II) complexes. XII International Symposium on Inorganic Biochemistry; Wroclaw; 28 August–1 September 2013
Duchler M, Pęczek Ł, Żuk K, Zaleśna I, Pluta P, Jeziorski A, Czyż M: Analysis of the immunosuppressive microenvironment in tumor samples from breast cancer patients. 3rdInternational Cancer Immunotherapy & Immunomonitoring CITIM; Cracow; 22-25 April 2013
Czyż M, Koprowska K, Hartman M, Zaleśna I, Duechler M, Sztiller-Sikorska M: Microenvironment-dependent phenotypic heterogeneity of melanoma cells. Cell Symposia: Hallmarks of Cancer; San Francisco, USA; 29-31 October 2012
Szubert M, Kowalczyk-Amico K, Szuławska A, Duechler M, Czyż M, Suzin J: Angiogenesis and inflammatory response in endometriosis – the role of danazol treatment. 15th World Congress of Gynecological Endocrinology; Firenze, Italy; 7-10 March 2012
Szubert M, Duechler M, Szuławska A, Suzin J, Czyż M, Kowalczyk-Amico K: Biomarkers of angiogenesis and inflammatory response in peritoneal fluid of women with endometriosis. 5th World Congress of Gynecological Endocrinology; Firenze, Italia; 7-10 March 2012; Giornale Italiano Ostetricia Ginecologia 34: 321-322
Koprowska K, Jakubowska J, Sztiller-Sikorska M, Czyż M: Parthenolide enhances the anti-tumor efficacy of dacarbazine and temozolomide in melanoma cells with cancer stem cells properties.FEBS Advanced Lecture Course on Translational Cancer Research; Portugal; 27 September-4 October 2011
Czyż M (Invited Speaker): Reversible phenotypic heterogeneity among melanoma stem-like cells. The 5th Polish-French Conference on Cancer Biology and Therapy; Paris, France; 30 May-1 June 2011
Czyż M, Lesiak-Mieczkowska K, Szuławska-Mroczek A, Woźniak M, Jakubowska J: Targeting constitutive and inducible NF-κB pathway by parthenolide in primary and metastatic melanoma cells. Perspectives in Melanoma XIV; Amsterdam, Netherlands; 17-18 September 2010
Grażul M, Czyż M, Kufelnicki A, Woźniczka M, Budzisz E: Structure, protonation constants and cytotoxic effect of Co(II) and Pd(II) ion complexes with chromone ligand in melanoma cells. ISABC 10, 10th Internacional Symposium on Applied Bioinorganic Chemistry; Debrecen, Hungary; 25-28 September 2009
Koprowska K, Stasiak M, Czyż M: Cell cycle arrest or apoptosis are induced by parthenolide and cisplatin in melanoma cells in vitro. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16-19 September 2009; Acta Biochemica Polonica 56: 50
Szuławska-Mroczek A, Woźniak M, Lesiak K, Czyż M: Effects of parthenolide and cisplatin on the NFκB-binding activity and expression of NFκB-dependent genes in melanoma cells. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16-19 September 2009; Acta Biochemica Polonica 56: 51
Lesiak K, Zaleśna I, Nejc D, Czyż M: Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anti-cancer activity against human melanoma cells in vitro. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16–19 September 2009; Acta Biochemica Polonica 56: 50
Jakubowska J, Sztiller-Sikorska M, Woźniak M, Stasiak M, Czyż M: Similarities between pharmacologically induced differentiation of K562 cells and normal erythropoiesis. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16–19 September 2009; Acta Biochemica Polonica 56: 109
Sztiller-Sikorska M, Jakubowska J, Stasiak M, Czyż M: Caspase-3 is involved in chemically induced erythroid differentiation of K562 cell line. The Congress of Biochemistry and Cell Biology, 43rd Meeting of the Polish Biochemical Society and 10th Conference of the Polish Cell Biology Society; Olsztyn; 7-11 September 2008; Acta Biochemica Polonica 55: 76
Jakubowska J, Stasiak M, Sztiller-Sikorska M, Czyż M: Combined effects of STI571 and doxorubicin on growth, differentiation and apoptosis of K562 cell line. Apoptosis World 2008 – From mechanisms to applications; Luxembourg; 23-26 January 2008
Lesiak K, Duchler M, Czyż M: NF-κB inhibitors as novel approach against malignant melanoma. Apoptosis World 2008 – From mechanisms to applications; Luxembourg; 23-26 January 2008
Czyż M, Jakubowska [Arkusińska] J, Stasiak M, Szuławska A: Cooperative effects of STI571 (imatinib) and doxorubicin in promoting erythroid differentiation and apoptosis in CML cell line K562.42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 51-52
Jakubowska [Arkusińska] J, Stasiak M, Benarek A, Czyż M: STI571 (imatinib) and doxorubicin induction of erythroid differentiation and apoptosis in CML cell line K562 is accompanied by dissipation. 42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 151
Lewandowska U, Płuciennik E, Czyż M, Hrabec E, Bednarek A: The role of WWOX normal and pathological cell metabolism. 42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 53
Czyż M, Jakubowska J, Stasiak M, Szuławska A: Combinatorial effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell like K562. BIT’s 5th Anniversary Congress of International Drug Discovery Science and Technology (IDDST); Shanghai, China; 28 May-5 June 2007
Duechler M, Stańczyk M, Czyż M, Stępnik M: Parthenolide and buthionine sulfoximine potentiate cytotoxicity of arsenic trioxide. BIT’s 5th Anniversary Congress of International Drug Discovery Science and Technology (IDDST); Shanghai, China; 28 May-5 June 2007